search icon

    Market Snapshot

    • S&P Futures

      3,914.75

    • Dow Futures

      31,478

    • Nasdaq Futures

      12,132.75

    blog search icon

    Beam Therapeutics Inc.

    (NASDAQ:BEAM)

    $41.57

    $2.44

    6.24%

    Beam Therapeutics Inc. Chart

    BEAM Stock Price Today

    Beam Therapeutics Inc. (BEAM) stock rallied over 6.24% intraday to trade at $41.57 a share on NASDAQ. The stock opened with a gain of 18.77% at $39.34 and touched an intraday high of $41.83, rising 6.24% against the last close of $39.13. The stock went to a low of $38.3 during the session.

    Stock Snapshot

    $39.13

    Prev. Close

    2.63 Billion

    Market Cap

    $38.3

    Day Low

    $39.34

    Open

    68.7 Million

    Number of Shares

    $41.83

    Day High

    -

    P/E ratio

    -3.61

    EPS (TTM)

    14.28

    Cash Flow per Share

    16.54

    Free Float in %

    12.85

    Book Value

    1,256,236

    Volume

    Beam Therapeutics Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-06-23$39.34$41.83$38.3$41.571,258,200
    2022-06-22$35$39.99$34.47$39.131,558,400
    2022-06-21$36.82$39.61$36.82$38.051,581,300
    2022-06-17$33.11$36.94$32.95$35.773,677,700
    2022-06-16$30.38$32.565$29.52$32.231,484,200
    2022-06-15$31.24$33.05$30.7$31.951,641,000
    2022-06-14$30.09$30.93$28.57$30.831,326,100
    2022-06-13$31.22$31.61$28.04$29.862,029,200
    2022-06-10$35.97$36.39$32.52$33.081,236,500
    2022-06-09$39.5$40.05$37.74$37.795674,600

    Contact Details

    238 Main Street
    9th Floor
    Cambridge, MA 02142
    United States

    Webiste:BEAM

    857 327 8775

    Company Information

    Employees-

    Beta-

    Sales or Revenue51.84 Million

    5Y Sales Change-

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia. It also develops therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1a; and therapies for ocular and central nervous system disorders. The company has a strategic alliance with Boston Children's Hospital; a research and clinical collaboration agreement with Magenta Therapeutics, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration with Apellis Pharmaceuticals, Inc. to apply base editing technology for discovering new treatments for complement-driven diseases. Beam Therapeutics Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.

    Frequently Asked Questions

    icon

    What is the current Beam Therapeutics Inc. (BEAM) stock price?

    Beam Therapeutics Inc. (NASDAQ: BEAM) stock price is $41.57 as of the last check on Thursday, June 23. During the trading session, BEAM stock reached the peak price of $41.83 while $38.3 was the lowest point it dropped to.

    icon

    BEAM's industry and sector of operation?

    The NASDAQ listed BEAM is part of Biotechnology industry that operates in the broader Health Care sector. Beam Therapeutics Inc. , a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States.

    icon

    Who are the executives of BEAM?

    Mr. John M. Evans M.B.A.
    CEO & Director
    Dr. Giuseppe Ciaramella Ph.D.
    Pres & Chief Scientific Officer
    Ms. Terry-Ann Burrell M.B.A.
    CFO & Treasurer
    Dr. Alexis Komor Ph.D.
    Co-Founder

    icon

    What is the BEAM stock price today?

    BEAM stock traded closed the last session at $41.57, which is $2.44 or 6.24% lower than its previous close of $39.13. BEAM's current trading price is 49.69% lower than its 52-week high of $138.52 where as its distance from 52-week low of 27.77% is -69.99%.

    icon

    How many employees does BEAM have?

    Number of BEAM employees currently stands at -. BEAM operates from 238 Main Street, 9th Floor, Cambridge, MA 02142, United States.

    icon

    Link for BEAM official website?

    Official Webiste of $BEAM is: https://www.beamtx.com

    icon

    How do I contact BEAM?

    BEAM could be contacted at BEAM operates from 238 Main Street, 9th Floor, Cambridge, MA 02142, United States, or at phone #857 327 8775 and can also be accessed through its website.

    icon

    How many shares of BEAM are traded daily?

    BEAM stock volume for the day was 1,256,236 shares while in the previous session number of BEAM shares traded was 1,258,200 . The average number of BEAM shares traded daily for last 3 months was 1.32 Million.

    icon

    How much did BEAM change today?

    The percentage change in BEAM stock occurred in the recent session was 6.24% while the dollar amount for the price change in BEAM stock was $2.44.

    icon

    What price range BEAM stock been trading in?

    In the recent session, the day high for BEAM stock was $41.83 while the low for BEAM stock touched on the day was $38.3.

    icon

    What is the market cap of BEAM currently?

    The market value of BEAM currently stands at 2.63 Billion with its latest stock price at $41.57 and 68.7 Million of its shares outstanding.